Sign In
Buy CMPX
$2.10
+0.0200 (+0.96%)
At Close: Jun 03, 2026
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
07:30am, Wednesday, 17'th Dec 2025
BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, to
Wall Street Analysts Think Compass Therapeutics, Inc. (CMPX) Could Surge 134.14%: Read This Before Placing a Bet
10:56am, Friday, 12'th Dec 2025
The consensus price target hints at a 134.1% upside potential for Compass Therapeutics, Inc. (CMPX). While empirical research shows that this sought-after metric is hardly effective, an upward trend i
Here's Why Compass Therapeutics, Inc. (CMPX) is a Great Momentum Stock to Buy
01:00pm, Monday, 08'th Dec 2025
Does Compass Therapeutics, Inc. (CMPX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of “Moderate Buy” from Analysts
01:10am, Monday, 08'th Dec 2025
Compass Therapeutics, Inc. (NASDAQ: CMPX - Get Free Report) has received a consensus rating of "Moderate Buy" from the fifteen analysts that are currently covering the stock, Marketbeat.com reports. O
Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript
05:08pm, Thursday, 04'th Dec 2025
Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript
Compass Therapeutics, Inc. (CMPX) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
04:48pm, Thursday, 04'th Dec 2025
Compass Therapeutics, Inc. (CMPX) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Pre-Market Stock Futures: The futures are trading higher on Wednesday after a stellar day across Wall Street on Tuesday. All of the major indices finished the day higher, with the technology-heavy NAS
Wall Street Analysts Believe Compass Therapeutics, Inc. (CMPX) Could Rally 154.09%: Here's is How to Trade
10:56am, Wednesday, 26'th Nov 2025
The mean of analysts' price targets for Compass Therapeutics, Inc. (CMPX) points to a 154.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agre
Compass Therapeutics to Participate in Upcoming December Investor Events
08:00am, Tuesday, 25'th Nov 2025
BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, to
2025's Top 3 Breakout Stocks for Active Traders: Don't Miss Out!
04:00pm, Thursday, 20'th Nov 2025
ORLA, FIGS and CMPX emerge as breakout candidates as traders scan for stocks nearing or clearing key resistance levels.
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
07:30am, Wednesday, 05'th Nov 2025
Based on a continuing trend of decreased mortality in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC), t
CTX-10726 demonstrated potent, simultaneous inhibition of tumor angiogenesis and PD-1-mediated immune suppression, and eliminated tumors in multiple preclinical studies. In vivo, CTX-10726 outperforme
Compass Therapeutics to Participate in Upcoming November Investor Events
08:00am, Monday, 03'rd Nov 2025
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based
Compass Therapeutics (NASDAQ:CMPX) & XOMA Royalty (NASDAQ:XOMA) Head-To-Head Survey
01:48am, Wednesday, 22'nd Oct 2025
Compass Therapeutics (NASDAQ: CMPX - Get Free Report) and XOMA Royalty (NASDAQ: XOMA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the
Compass Therapeutics, Inc. (CMPX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
02:06am, Wednesday, 10'th Sep 2025
Compass Therapeutics, Inc. (NASDAQ:CMPX ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 5:35 PM EDT Company Participants Thomas Schuetz - CEO & Vice Chairman Barry Shin - C
